60-Day FRN

2024-06803 FRN 0990-0263 60-day.pdf

Protection of Human Subjects Assurance Identification/IRB Certification/Declaration of Exemption

60-Day FRN

OMB: 0990-0263

Document [pdf]
Download: pdf | pdf
22413

Federal Register / Vol. 89, No. 63 / Monday, April 1, 2024 / Notices
Dated: March 25, 2024.
Violet Woo,
Designated Federal Officer, Advisory
Committee on Minority Health.
[FR Doc. 2024–06850 Filed 3–29–24; 8:45 am]
BILLING CODE 4150–29–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–0263]

Agency Information Collection
Request; 60-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.

AGENCY:
ACTION:

In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before May 31, 2024.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 264–0041 and PRA@HHS.GOV.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990–0263–60D
SUMMARY:

and project title for reference, to
Sherrette A. Funn, email:
Sherrette.Funn@hhs.gov, PRA@
HHS.GOV or call (202) 264–0041 the
Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Protection of
Human Subjects: Assurance
Identification/IRB Certification/
Declaration of Exemption Form.
Type of Collection: Renewal, threeyear extension with non-substantive
changes for the Protection of Human
Subjects: Assurance Identification/IRB
Certification/Declaration of Exemption
Form OMB No. 0990–0263 Office of the
Assistant Secretary for Health, Office for
Human Research Protections.
Abstract: The Office of the Assistant
Secretary for Health, Office for Human

Research Protections is requesting is
requesting a three-year extension with
non-substantive changes of the
Protection of Human Subjects:
Assurance Identification/IRB
Certification/Declaration of Exemption
Form, OMB No. 0990–0263.
The information collected on the form
is to provide a simplified method for
institutions engaged in research
conducted or supported by the
Department of Health and Human
Services (HHS) to satisfy the
requirements of HHS regulations for the
protection of human subjects at 45 CFR
46.103 for assurance identification and
institutional review board (IRB)
certification and declare exemption
status. Non-substantive changes include
adding instructions that, if additional
assurances apply, those details can be
indicated in the ‘‘Comments’’ section
and clarifying that the form element for
IRB expiration date does not apply to all
projects.
Likely Respondents: Institutions
engaged in research involving human
subjects where the research is supported
by HHS. Institutional use of the form is
also relied upon by other Federal
departments and agencies that have
codified or follow the Federal Policy for
the Protection of Human Subjects
(Common Rule), which is codified for
HHS at 45 CFR part 46, subpart A.

ANNUALIZED BURDEN HOUR TABLE
Form name

Number of
respondents

Number of
responses per
respondent

Hours per
response

Response
burden hours

Protection of Human Subjects: Assurance Identification/IRB Certification/
Declaration of Exemption .............................................................................

13,000

2

0.5

13,000

Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2024–06803 Filed 3–29–24; 8:45 am]
BILLING CODE 4150–36–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

ddrumheller on DSK120RN23PROD with NOTICES1

National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections

VerDate Sep<11>2014

17:17 Mar 29, 2024

Jkt 262001

552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Planning Grants (R34); NIAID Clinical Trial
Implementation Cooperative Agreement
(U01); NIAID SBIR Phase II Clinical Trial
Implementation Cooperative Agreement
(U44); Investigator Initiated Extended
Clinical Trial (R01).
Date: April 30–May 1, 2024.
Time: 9:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.

PO 00000

Frm 00042

Fmt 4703

Sfmt 4703

Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F21B,
Rockville, MD 20852 (Video Assisted
Meeting).
Contact Person: Maryam Feili-Hariri,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F21B,
Rockville, MD 20852, 240–669–5026,
haririmf@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 26, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–06859 Filed 3–29–24; 8:45 am]
BILLING CODE 4140–01–P

E:\FR\FM\01APN1.SGM

01APN1


File Typeapplication/pdf
File Modified2024-03-30
File Created2024-03-30

© 2024 OMB.report | Privacy Policy